0000007307 00000 n The wound assessment must be completed by a registered nurse or other healthcare professional. The WoundReference Digital Formulary Module is available in all WoundReference plans, including the Free Basic Plan (see Plans). We have previously shown that implementation of a local wound care formulary may result inmore than 38% savings in inventory costs and increased staff efficiency. Mf8Oa*C[&1d9J^. Antibacterial preparations only used topically, 13.10.1.2. 1.1 Dyspepsia and gastro-oesophageal reflux disease (GORD), 1.1.2 Compound alginates and proprietary indigestion preparations, 1.2 Antispasmodics and other drugs altering gut motility, 1.3 Antisecretory drugs and mucosal protectants, 1.5.1.1 Acute Exacerbation of ulcerative colitis, 1.5.1.2 Maintenance of remission of ulcerative colitis, 1.5.2 Corticosteroids inflammatory bowel disease, 1.5.3 Steroid-sparing treatment for inflammatory bowel disease, 1.7 Local preparations for anal and rectal disorders, 1.7.1 Soothing haemorrhoidal preparations, 1.7.2 Compound haemorrhoidal preparations with corticosteroids, 1.9 Drugs affecting intestinal secretions, 2.2.3 Potassium-sparing diuretics and aldosterone antagonists, 2.2.4 Potassium-sparing diuretics with other diuretics, 2.5.2 Centrally acting antihypertensive drugs, 2.5.5 Drugs affecting the renin-angiotensin system, 2.5.5.1 Angiotensin-converting enzyme inhibitors, 2.5.5.2 Angiotensin-II receptor antagonists (AIIRAs/ARBs), 2.6 Nitrates, calcium-channel blockers and other antianginal drugs, 2.6.4 Peripheral vasodilators and related drugs, 2.8.2.2 Treatment of pulmonary embolism and deep vein thrombosis and prevention of recurrent, 2.8.2.3 Prophylaxis of venous thromboembolism in orthopaedics-specialist use in secondary care only, 2.8.2.5 Prevention of Atherothrombotic events, 2.10 Stable angina, acute coronary syndromes and fibrinolysis, 2.11 Antifibrinolytic drugs and haemostatics, 3.1.4 Compound bronchodilator preparations, 3.1.5 Peak flow meters, inhaler devices and nebulisers, 3.2.1 Single agent inhalers [asthma only], 3.2.2 Compound ICS/LABA preparations [asthma], 3.2.3 Compound ICS/LABA preparations COPD, 3.3 Leukotriene receptor antagonists and phosphodiesterase type-4 inhibitors, 3.3.3 Phosphodiesterase type-4 inhibitors, 3.4 Antihistamines, hyposensitisation and allergic emergencies, 3.4.2 Allergen immunotherapy (desensitisation), 4.2 Drugs used in psychoses and related disorders, 4.2.1.1 Management of agitation and aggression, 4.2.3.1 Treatment of the acute phase of mania, 4.2.3.2 Maintenance treatment of bipolar disorder with mood stabilisers, 4.3.1 Mild, moderate and severe depression, 4.3.2 Antidepressants for the treatment of anxiety disorders*, 4.3.2.1 Generalised anxiety disorder (GAD), social anxiety disorder, 4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder, 4.4.2 Attention deficit hyperactive disorder (ADHD) in adults, 4.5 Drugs used in the treatment of obesity, 4.5.1 Anti-obesity drugs acting on the gastro-intestinal tract, 4.6.1 Drugs for the short-term treatment of nausea and vomiting, 4.7.4.1 Treatment of acute migraine attack, 4.7.4.3 Drug treatment of cluster headache, 4.9 Drugs used in parkinsonism and related disorders, 4.9.1 Dopaminergic drugs used in parkinsonism, 4.9.1.3 Monoamine-oxidase-B (MAOB) inhibitors, 4.9.1.4 Catechol-O-methyltransferase inhibitors (COMT inhibitors), 4.9.2 Antimuscarinic drugs used in parkinsonism, 4.9.4 Management of dementia in Parkinsons disease, 4.10 Medications used in substance use disorders, 4.10.3 Benzodiazepine and Z drug withdrawal, 4.10.4.3 Interventions for the reduction of alcohol consumption, 4.11.1 Management of Behavioural and Psychological Symptoms of Dementia (BPSD), 6.1.2.3 Dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors), 6.1.2.5 Sodium-glucose co-transporter 2 (SGLT-2) inhibitors, 6.1.6 Diagnostic and monitoring agents for diabetes mellitus, Summary of oral drug treatments for type 2 diabetes, 6.2 Thyroid and antithyroid drugs and parathyroid disease, 6.4.1.1 Hormone replacement therapy (HRT) for menopausal symptoms, 6.4.1.1a Women who have not had a hysterectomy, 6.4.1.1b Women who have had a hysterectomy or who have a Mirena Intra Uterine System (ISU) in situ, 6.5 Pituitary hormones and anti-oestrogens, 6.5.2 Posterior pituitary hormones and antagonists, 6.5.2.2 Antidiuretic hormone antagonists, 6.6.1 Drugs for the treatment and management of osteoporosis, 6.6.1.3 Other drug therapies used in osteoporosis, 7.0 Contraception, Gynaecology and Urinary Tract Disorders, 7.1.3 Endometriosis (previously diagnosed by laparoscopy), 7.2 Treatment of vaginal and vulval conditions, 7.2.1 Preparations for vaginal and vulval changes, Review copy of Review copy of 7.2.2 Vaginal and vulval infections, 7.3.1 Combined hormonal oral contraceptives, 7.3.2.1 Oral progestogen-only contraceptives, 7.3.2.2 Parenteral progestogen-only contraceptives, 7.3.2.3. "Can I Shower?" NICE, London National Institute for Health and Care Excellence (2020) Venous eczema and lipodermatosclerosis. Volume 13 - 2022; Volume 12 - 2021; Volume 14-2023; Volume 11 - 2020; Volume 10 - 2019; Volume 9 - 2018; Volume 8 - 2017; Volume 7 - 2016; Volume 6 - 2015; Volume 5 - 2014; Volume 4 - 2013; Volume 3 . World Union of Wound Healing Societies (2020) Strategies to reduce practice variation in wound assessment and management: The T.I.M.E. Or browse to enjoy free content and tools. - September 24, 2020, Increasing HBOT Referrals | Skin Essentials & Principles of Wound Healing | A Peek Into 2021 CMS Reimbursement - August 27, 2020, Skin Essentials | A Peek Into 2021 CMS Reimbursement - August 27, 2020, Patient Education For Successful Wound Care TeleVisits | Wound and HBOT Digital Tools Poster Gallery | Network With Colleagues - July 16, 2020, HBOT for Gas Gangrene CME/CE/Category A | Patient Education For Successful Wound TeleVisits | Wound and HBOT Digital Tools Poster Gallery - July 16, 2020, Telehealth Beyond COVID-19: Transforming Best Practice in Wound Care | HBOT for Compromised Grafts and Flaps - June, 2020, Updates and resources for wound care & HBOT during COVID-19 and beyond | Surgical Ostomies - May, 2020, WoundReference offers clinicians free use of the TeleVisit Tool - March 20, 2020, Offloading solved: how to select offloading devices for DFUs - Feb 7, 2020, Webinar - Unwrapping Venous Leg Ulcers (free CNE) | Offloading Devices - Evidence, Practice, Reimbursement | HBOT Category A Credits - Jan 28, 2020, More Online, Self-Paced Hyperbaric Category A Continuing Education | No More Tears Part 2 - Skin Tears Treatment and Prevention - Jan 10, 2020, Online, Self-Paced Hyperbaric Category A Continuing Education | Nutrition for Wound Healing - Patient Education - Dec 20, 2019, No More Tears - Understanding Skin Tears (Part I) | HBOT for Acute Traumatic Ischemia, Crush Injury and Compartment Syndrome - What's New? 2.0 27/12/2017 Review of formulary Updated products no longer available with alternatives. 0000045321 00000 n This wound care formulary companion provides clinical staff with a comprehensive guide to wound dressing products. |X -Q4zLh0Z8j!%F6U0Ta E1C /eRS",ZxfQ(4.F2Ei Yyjs [6(! Having 2-3 products may come in handy so you have a fall back plan in case of product shortages. If you are considering adding a product to your formulary that you have not used before, call the manufacturer sales rep and ask for samples and educational materials. Adult Primary Care Antibiotic Guidelines; Paediatric Primary Care Antibiotic Guidelines; Fosfomycin - prescribing and supply; Penicillin allergy; Guidance on the Management of Proven or Suspected Staph. | Wound Care ICD-10 Coding - Oct 25, 2019, Coding and Reimbursement Guidelines for Wound Care | 2020 ICD-10 Codes for Wound Care: Updates and Interactive Tool - Oct 18, 2019, Reducing Errors and Liability in Wound Care | ICD-10 Codes: 2020 Updates and Interactive Tool for Wound Care Professionals - Oct 11, 2019, Defining Your Wound Care Program's Scope of Service | Transfer of Post-operative Care to the Wound Clinic - Oct 4, 2019, How to Perform Conservative Sharp Wound Debridement: Protocols, Troubleshooting, Reimbursement | Digital Formulary - Sept 18, 2019, Post-operative Care by Wound Services: Getting Reimbursed | Is Adjunct HBOT Effective for Female Infertility? Is there a budget for each type of product? If you need to eliminate or add some brands to each product type, ask your team: What makes a product worth including in your formulary? Increasing HBOT Referrals | Skin Essentials & Principles of Wound Healing | A Peek Into 2021 CMS Reimbursement, Skin Essentials | A Peek Into 2021 CMS Reimbursement, Patient Education For Successful Wound Care TeleVisits | Wound and HBOT Digital Tools Poster Gallery | Network With Colleagues, HBOT for Gas Gangrene CME/CE/Category A | Patient Education For Successful Wound TeleVisits | Wound and HBOT Digital Tools Poster Gallery, Telehealth Beyond COVID-19: Transforming Best Practice in Wound Care | HBOT for Compromised Grafts and Flaps, Updates and resources for wound care & HBOT during COVID-19 and beyond | Surgical Ostomies, WoundReference offers clinicians free use of the TeleVisit Tool, Offloading solved: how to select offloading devices for DFUs, Webinar - Unwrapping Venous Leg Ulcers (free CNE) | Offloading Devices - Evidence, Practice, Reimbursement | HBOT Category A Credits, More Online, Self-Paced Hyperbaric Category A Continuing Education | No More Tears Part 2 - Skin Tears Treatment and Prevention, Online, Self-Paced Hyperbaric Category A Continuing Education | Nutrition for Wound Healing - Patient Education. ##gG%XP /PLlPd$KcBGg00aZd &U%:y 7: Obstetrics, gynaecology & urinary tract disorders, 17: Wound Management (Dressings) Formulary, 18: Continence and Urology Products (Adults), NICE Technology Appraisals / Highly Specialised Technologies Guidance, Join our Foundation Trust today and support our hospitals. 4 0 obj - Nov 9, 2019, "Can I Shower?" ?[xmW"/[t82vvV[tvur(9bsV/f?I[4(2y-nQtQ2C j(Hto&OQ FfN@jb-,CWE/iQT@:@?ls5[/*8pq,QsiLg7+WPJMC`2fb{>i#HEeGy6!i"b'Z+;X0{oS1+x|G1I 4c?1\j6TT(Oy,xOJN8'RL*?^0WS!0 Kv ~lm S-K%G2k3 tKP8Z*RqcK=C%)e`. B"S?VJXZ o xAGTXQ(/\//UaU9?el&#'F@%T[g@j2'%X) @k^&mgfi)UF- io>K7S`a* M m+RR89t`Fv2_JwH`m[~ u4 az P9DeFOD|JDOmUT*l6q5Ni:Q3 QSeN ;T%!CeUf:vB ]putU"p&"tiMGEAcPZu8PYaQ\". J Product Available Sizes SKU PECOS Pack Size . Intra-uterine progestogen-only device, 7.3.6 Delaying Menstruation During Holidays, 7.4.1 Drugs for voiding (obstructive) symptoms in men, 7.4.2 Drugs for urinary frequency, enuresis, and incontinence, 8.0 Malignant Disease and Immunosuppression, 9.1 Anaemias and some other blood disorders, 9.1.2 Drugs used in megaloblastic anaemias, 9.4.1 Step 1-Identification of nutritional risk, 9.4.2-Step 2-Underlying causes of malnutrition, 9.4.4-Step 4-Discuss Food First dietary advice, Supplementations in pregnancy/ pre-conception, 10.1 Drugs use in rheumatic diseases and gout, 10.1.3 Drugs that suppress the rheumatic disease process, 10.1.4 Gout and cytotoxic-induced hyperuricaemia, 10.1.5 Other drugs for rheumatic diseases, 10.2 Drugs used in neuromuscular disorders, 10.2.1 Drugs that enhance neuromuscular transmission, 10.3 Drugs used for the treatment of soft-tissue disorders and topical pain relief, 10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices, 13.2.1.1 Emollient bath and shower preparations, 13.3.
Shield Annuity Pros And Cons, Articles W